Infect Chemother.
2021 Dec;53(4):792-795. 10.3947/ic.2021.0085.
Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
- 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
- 3Department of Internal Medicine, Boramae Medical Center, Seoul, Korea
- KMID: 2524075
- DOI: http://doi.org/10.3947/ic.2021.0085
Abstract
- Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes. This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Proportion of Multidrug-Resistant Tuberculosis in Human Immunodeficiency Virus/Mycobacterium tuberculosis Co-Infected Patients in Korea
- Risk Factors for Primary Multidrug Resistant Tuberculosis
- Differentiating between Intestinal Tuberculosis and Crohn’s Disease May Be Complicated by Multidrug-resistant Mycobacterium tuberculosis
- The survey for clinical course of intractable pulmonary tuberculosis
- Multidrug-resistant Tuberculosis Spondylitis: A Case Report
